Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Rituximab 49Cyclophosphamide 28venetoclax 24Bendamustine Hydrochloride 24obinutuzumab 22ibrutinib 21Chlorambucil 20fludarabine 16fludarabine phosphate 15idelalisib 13acalabrutinib 11pirtobrutinib 7ofatumumab 7zanubrutinib 5Vincristine 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Cyclosporine 5Radiotherapy 4Prednisone 4Doxorubicin 4duvelisib 3Whole-Body Irradiation 3Specimen Handling 3Methotrexate 3Lenalidomide 3Filgrastim 3Epoetin Alfa 3Cyclosporins 3Biopsy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Lymphocytic, Chronic, B-Cell × Pneumococcal Vaccines × Clear all
NCT01892618 2016-01-15

Pneumococcal Vaccine in Untreated CLL Patients

Karolinska University Hospital

Phase 3 Completed
134 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡